Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President, CEO and Chairman

Senior Vice President

Senior VP, Development

Chief Financial Officer

Dermata Therapeutics, Inc., a clinical-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Dermata Therapeutics, Inc., a clinical-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmace...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2022-10-06	Premium	acquired	Premium	Premium	Premium	-
2022-10-06	Premium	acquired	Premium	Premium	Premium	-
2022-10-06	Premium	acquired	Premium	Premium	Premium	-
2022-10-06	Premium	acquired	Premium	Premium	Premium	-
2022-10-06	Premium	acquired	Premium	Premium	Premium	-
2022-10-06	Premium	acquired	Premium	Premium	Premium	-
2022-07-07	Premium	acquired	Premium	Premium	Premium	-
2022-07-07	Premium	acquired	Premium	Premium	Premium	-
2022-07-07	Premium	acquired	Premium	Premium	Premium	-
2022-07-07	Premium	acquired	Premium	Premium	Premium	-
2022-07-07	Premium	acquired	Premium	Premium	Premium	-
2022-07-07	Premium	acquired	Premium	Premium	Premium	-
2022-04-07	Premium	acquired	Premium	Premium	Premium	-
2022-04-07	Premium	acquired	Premium	Premium	Premium	-
2022-04-07	Premium	acquired	Premium	Premium	Premium	-
2022-04-07	Premium	acquired	Premium	Premium	Premium	-
2022-04-07	Premium	acquired	Premium	Premium	Premium	-
2022-04-07	Premium	acquired	Premium	Premium	Premium	-
2021-11-23	Premium	bought	Premium	Premium	Premium	President, CEO and Chairman
2021-08-17	Premium	acquired	Premium	Premium	Premium	Senior Vice President
2021-08-17	Premium	acquired	Premium	Premium	Premium	-
2021-08-17	Premium	bought	Premium	Premium	Premium	President, CEO and Chairman
2021-08-17	Premium	acquired	Premium	Premium	Premium	Senior VP, Development
2021-08-17	Premium	acquired	Premium	Premium	Premium	-
2021-08-17	Premium	acquired	Premium	Premium	Premium	President, CEO and Chairman

DRMA - Dermata Therapeutics, Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for DRMA